1. Important Notes
This semi-annual report summary is derived from the full semi-annual report. To fully understand the company's operating results, financial position, and future development plans, investors should carefully read the full semi-annual report on the China Securities Regulatory Commission's designated media outlet, Juchao Information (www.cninfo.com.cn). All directors attended the board meeting to review this report. The company does not plan to distribute cash dividends, issue bonus shares, or convert capital reserves into share capital.
2. Basic Company Information
1. Company Profile
| Stock Abbreviation | Betta Pharmaceuticals | Stock Code | 300558 |
|---|---|---|---|
| Stock Exchange | Shenzhen Stock Exchange | ||
| Contact Person | Board Secretary | Securities Affairs Representative | |
| Name | Ding Lieming (Acting Chairman) | Shen Jianhao | |
| Telephone | 0571-89265665 | 0571-89265665 | |
| Office Address | No. 355 Xingzhong Road, Economic and Technological Development Zone, Linping District, Hangzhou | No. 355 Xingzhong Road, Economic and Technological Development Zone, Linping District, Hangzhou | |
| betta0107@bettapharma.com | betta0107@bettapharma.com |
2. Key Accounting Data and Financial Indicators
The company does not need to retrospectively adjust or restate accounting data from previous years.
| Current Reporting Period | Same Period Last Year | Change (%) | |
|---|---|---|---|
| Operating Income (RMB) | 1,975,927,792.57 | 1,731,412,742.27 | 14.12% |
| Net Profit Attributable to Shareholders (RMB) | 302,134,274.28 | 139,897,221.85 | 115.97% |
| Net Profit After Deducting Non-Recurring Gains/Losses (RMB) | 203,403,701.74 | 190,623,726.76 | 6.70% |
| Net Cash Flow from Operating Activities (RMB) | 412,339,704.08 | 444,978,288.21 | -7.33% |
| Basic Earnings Per Share (RMB/share) | 0.72 | 0.33 | 118.18% |
| Diluted Earnings Per Share (RMB/share) | 0.71 | 0.33 | 115.15% |
| Weighted Average Return on Net Assets | 4.61% | 2.53% | 2.08% |
| Total Assets (RMB) | 10,299,391,770.42 | 10,565,646,587.69 | -2.52% |
| Net Assets Attributable to Shareholders (RMB) | 6,625,836,980.33 | 6,595,157,402.93 | 0.47% |
3. Shareholder Quantity and Shareholding Status
Unit: Shares
| Total Common Shareholders at Period End | 49,777 | Total Preferred Shareholders with Restored Voting Rights | 0 | Total Shareholders with Special Voting Rights | 0 |
|---|